Prometheus Biosciences is a forward-thinking biopharmaceutical company that is dedicated to disrupting the treatment paradigm of GI diseases. We will do this by discovering and developing a broad portfolio of novel precision therapeutics and diagnostics that will meaningfully impact patient care.

Profile

Social Media

Prometheus Biosciences Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mark McKenna

Chief Financial Officer

Keith Marshall

Chief Medical Officer

Allison Luo

Chief Operating Officer

Lauren Otsuki

Chief Scientific Officer

Laurens Kruidenier

Chief Technical Officer

Olivier Laurent

Vice President

Brian Littlefield

VP - Bus. Development

Robert Armstrong

VP - Bus. Development

Thierry Dervieux

VP - Bus. Development

Michael Walther

VP - Finance

Vika Brough

Browse more venture capital transactions:

Prev: 11/10/2020: Stargazer Pharmaceuticals venture capital transaction
Next: 11/10/2020: Ambrx venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary